---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-094736"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:22:34.536215+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Organovo grants Chairman Murphy options on ~1M shares at $0.5368, vesting over 3 years

## Summary
- Time-based option for 574,923 shares vests 1/3 annually over 3 years subject to continued service.
- Performance-based option for 431,193 shares vests upon achieving revenue, market cap, stock price, and strategic goals.
- Additional 'True-Up Options' may be granted if equity financing closes by March 31, 2025, below specified dilution thresholds.
- Options granted under 2022 Equity Incentive Plan, approved by Compensation Committee on August 4, 2024.
- Exercise price set at $0.5368 per share; grant date is August 5, 2024.

## SEC filing metadata
- accession: 0000950170-24-094736
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000095017024094736/0000950170-24-094736-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000095017024094736/onvo-20240805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-094736
- JSON: https://secwatch.observer/filing/0000950170-24-094736.json
- Plain text: https://secwatch.observer/filing/0000950170-24-094736.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.